title: Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity.
abstract: BACKGROUND
  3,4-Methylenedioxymethamphetamine (MDMA) produces a neuroinflammatory reaction in rat brain characterized by an increase in interleukin-1 beta (IL-1β) and microglial activation. The CB2 receptor agonist JWH-015 reduces both these changes and partially protects against MDMA-induced neurotoxicity. We have examined MDMA-induced changes in IL-1 receptor antagonist (IL-1ra) levels and IL-1 receptor type I (IL-1RI) expression and the effects of JWH-015. The cellular location of IL-1β and IL-1RI was also examined. MDMA-treated animals were given the soluble form of IL-1RI (sIL-1RI) and neurotoxic effects examined.
  
  
  METHODS
  Dark Agouti rats received MDMA (12.5 mg/kg, i.p.) and levels of IL-1ra and expression of IL-1RI measured 1 h, 3 h or 6 h later. JWH-015 (2.4 mg/kg, i.p.) was injected 48 h, 24 h and 0.5 h before MDMA and IL-1ra and IL-1RI measured. For localization studies, animals were sacrificed 1 h or 3 h following MDMA and stained for IL-1β or IL-1RI in combination with neuronal and microglial markers. sIL-1RI (3 μg/animal; i.c.v.) was administered 5 min before MDMA and 3 h later. 5-HT transporter density was determined 7 days after MDMA injection.
  
  
  RESULTS
  MDMA produced an increase in IL-ra levels and a decrease in IL-1RI expression in hypothalamus which was prevented by CB2 receptor activation. IL-1RI expression was localized on neuronal cell bodies while IL-1β expression was observed in microglial cells following MDMA. sIL-1RI potentiated MDMA-induced neurotoxicity. MDMA also increased IgG immunostaining indicating that blood brain-barrier permeability was compromised.
  
  
  CONCLUSIONS
  In summary, MDMA produces changes in IL-1 signal modulators which are modified by CB2 receptor activation. These results indicate that IL-1β may play a partial role in MDMA-induced neurotoxicity.
authors: Departamento de Farmacologia, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain.
authors: Elisa
authors: E
authors: Torres
authors: Maria D
authors: MD
authors: Gutierrez-Lopez
authors: Andrea
authors: A
authors: Mayado
authors: Ana
authors: A
authors: Rubio
authors: Esther
authors: E
authors: O'Shea
authors: Maria I
authors: MI
authors: Colado
references: J Neuroimmunol. 2002 Apr;125(1-2):5-14
references: 11960635
references: J Neurosci. 1988 Aug;8(8):2788-803
references: 2457659
references: J Neurochem. 2002 Nov;83(4):754-63
references: 12421347
references: J Clin Invest. 1995 Jul;96(1):38-41
references: 7615809
references: Psychopharmacology (Berl). 1999 Mar;142(4):421-5
references: 10229068
references: Neuropharmacology. 1998 Jul;37(7):919-26
references: 9776387
references: J Pharmacol Exp Ther. 2005 Feb;312(2):694-701
references: 15456837
references: J Cereb Blood Flow Metab. 1996 Sep;16(5):932-40
references: 8784237
references: EMBO J. 1991 Oct;10(10):2821-32
references: 1833184
references: Stroke. 1998 Oct;29(10):2189-95
references: 9756602
references: J Neurochem. 2010 Apr;113(1):67-78
references: 20067581
references: Endocrinology. 1993 Apr;132(4):1497-504
references: 8462448
references: Cytokine. 1993 Sep;5(5):427-35
references: 8142597
references: Blood. 1997 Aug 1;90(3):1101-8
references: 9242541
references: Br J Pharmacol. 2001 Sep;134(1):46-57
references: 11522596
references: Neuropharmacology. 2003 Mar;44(4):449-61
references: 12646282
references: Psychopharmacology (Berl). 1991;105(1):113-8
references: 1684057
references: Neurotox Res. 2010 Aug;18(2):187-99
references: 19777321
references: J Neuroimmunol. 1999 Jan 1;93(1-2):194-202
references: 10378883
references: Eur J Neurosci. 2005 Jul;22(1):72-8
references: 16029197
references: Anal Biochem. 1976 May 7;72:248-54
references: 942051
references: J Neurosci. 2000 Nov 1;20(21):8153-9
references: 11050138
references: Neurosci Lett. 2008 Jan 17;430(3):258-63
references: 18061345
references: J Biol Chem. 1994 Feb 18;269(7):4705-8
references: 7508926
references: Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):323-40
references: 12220547
references: Br J Pharmacol. 1997 Jul;121(5):889-900
references: 9222545
references: Neuroscience. 1999;93(3):915-30
references: 10473257
references: Neuron. 2008 Jan 24;57(2):178-201
references: 18215617
references: Brain Res. 1994 Jun 27;649(1-2):265-70
references: 7953641
references: Hippocampus. 2009 Jul;19(7):670-6
references: 19115392
references: Br J Pharmacol. 1993 Mar;108(3):590-6
references: 8467354
references: J Neuroinflammation. 2008 Feb 27;5:8
references: 18304357
references: Neuroreport. 1999 Nov 26;10(17):3675-80
references: 10619665
references: J Cereb Blood Flow Metab. 1997 Oct;17(10):1107-20
references: 9346436
references: Neuropsychopharmacology. 2005 Aug;30(8):1492-9
references: 15900319
references: Ann N Y Acad Sci. 2005 Nov;1056:218-33
references: 16387690
references: Am J Pathol. 1990 Dec;137(6):1411-23
references: 2260629
references: Ann N Y Acad Sci. 2008 Oct;1139:242-58
references: 18991870
references: Eur J Neurosci. 1998 Mar;10(3):1188-95
references: 9753187
references: Neuroscience. 2005;135(4):1095-105
references: 16165281
references: Curr Neurovasc Res. 2010 Feb;7(1):39-48
references: 20158463
references: Br J Pharmacol. 2006 Jul;148(6):778-85
references: 16770327
references: Neuroscience. 2006;137(1):301-8
references: 16289587
references: Exp Neurol. 2001 Mar;168(1):23-31
references: 11170718
references: Br J Pharmacol. 2008 Jan;153(2):367-79
references: 17965748
references: Free Radic Biol Med. 2005 Jul 1;39(1):51-70
references: 15925278
references: J Neurosci. 2003 Apr 1;23(7):2511-6
references: 12684434
references: Exp Gerontol. 2007 Aug;42(8):762-71
references: 17592750
references: Brain Res Bull. 1992 Aug;29(2):243-6
references: 1388088
references: Physiol Behav. 1992 Jun;51(6):1277-9
references: 1386466
references: Nat Rev Immunol. 2010 Feb;10(2):89-102
references: 20081871
references: Brain Res Mol Brain Res. 2000 Dec 28;85(1-2):103-13
references: 11146112
references: Eur J Neurosci. 2005 May;21(9):2347-60
references: 15932594
references: Neuropharmacology. 1994 Dec;33(12):1589-95
references: 7539115
references: Neuroradiology. 1991;33(2):95-100
references: 2046916
references: J Biol Chem. 1951 Nov;193(1):265-75
references: 14907713
references: Acta Neuropathol. 2006 Mar;111(3):220-8
references: 16456668
references: J Neurochem. 2004 Jun;89(6):1445-53
references: 15189347